Amphastar Pharmaceuticals, Inc.
$1.32B- Market cap
- $986.88M
- Debt
- +$619.71M
- Cash
- −$282.81M
Capital structure 61% equity / 39% debt · EV / Revenue 1.84x · EV / EBITDA 6.20x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AMPH · current priceP/S 1.37x
$23.20Latest market snapshot
Implied fair value · at AEHR's multiple
$952.604,006.0% above market
16.92 AMPH revenue / share×56.29x AEHR P/S=$952.60
Market $23.20Implied $952.60
AEHR · current priceP/S 56.29x
$86.28Latest market snapshot
Implied fair value · at AMPH's multiple
$2.1097.6% below market
1.53 AEHR revenue / share×1.37x AMPH P/S=$2.10
Market $86.28Implied $2.10